Indian venture advances a 3D-printed patient-specific bone-graft platform
The Technology Development Board is supporting Ceramat's plan to commercialise customised calcium-phosphate implants for orthopaedic and dental use.
The Technology Development Board has announced financial assistance for Ceramat Pvt Ltd in Palghar to commercialise calcium-phosphate bone grafts, including patient-specific implants.
The platform uses Digital Light Processing and extrusion 3D printing. Its stated material range includes hydroxyapatite, beta-tricalcium phosphate, biphasic calcium phosphate and bioactive glass.
Why it matters
Domestic production of customised biomaterials could reduce reliance on imported implants and improve anatomical fit in complex orthopaedic and dental procedures.
SCULTRA point of view
The meaningful milestones are regulatory clearance, clinical evidence, manufacturing consistency, surgeon adoption and patient outcomes. Funding support alone does not establish commercial or clinical readiness.
Limitations
The accessible release does not state the assistance amount, total project cost, regulatory status, trial evidence or commercial launch date.
Source: Press Information Bureau / Technology Development Board, 9 September 2026.